ICYMI: LA TIMES – VACCINE MAKER GOT $1 BILLION FROM TAXPAYERS. NOW IT’S BOOSTING DRUG PRICES

Brand Name Drug Maker AstraZeneca Aggressively Raised Prices In The Middle Of A Pandemic, Even While Receiving Hundreds Of Millions In Taxpayer Funding Vaccine Maker Got $1 Billion From Taxpayers.

09-15-2020 Read More

ICYMI: STUDY SHOWS BIG PHARMA’S ANTI-COMPETITIVE GAMESMANSHIP COMES AT TREMENDOUS COST TO U.S. HEALTHCARE SYSTEM

Report Finds Just Five Instances Of Product Hopping Sticks Americans With $4.7 Billion Price Tag In case you missed it, a new study by Alex Brill of Matrix Global Advisors (MGA), commissioned by the

09-14-2020 Read More

CSRXP: PRESIDENT SHOULD FOCUS ON HOLDING BIG PHARMA ACCOUNTABLE TO LOWER RX PRICES, ABANDON REBATE RULE

Tweet Misstates Impact of Misguided Rebate Rule That Would Do Nothing to Lower Drug Prices, While Increasing Medicare Premiums For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected]

09-13-2020 Read More

ICYMI: REPORT CONFIRMS REBATE RULE WOULD HIKE PREMIUMS, COST TAXPAYERS BILLIONS OF DOLLARS AND BOOST “DRUG COMPANY REVENUES”

Study Finds Rebates Negotiated By PBMs Reduce Rx Costs and Lower Premiums – Eliminating Rebates Would Increase Costs On American Seniors & Taxpayers, While Handing Big Pharma a Bailout In case

09-8-2020 Read More

CSRxP Commends Congressional Probe Of Big Pharma Giant’s Anti-Competitive Tactics and Egregious Pricing Practices

U.S. House Oversight Committee Subpoena of AbbVie Related to Pricing of Blockbuster Cancer, Immunosuppressant Drugs Will Help Hold Industry Accountable For Immediate Release Contact: Jon Conradi

09-1-2020 Read More

ICYMI: STAT NEWS – NEW POLL SHOWS WIDE SUPPORT FOR SEVERAL TRUMP DRUG PRICING REFORMS, BUT NOT REBATE CHANGES

Administration Should Shelve Rebate Rule That Would Increase Medicare Premiums, Cost Taxpayers $200 Billion and Hand Big Pharma a Massive Bailout In case you missed it, a new poll first reported by

08-28-2020 Read More

BIG PHARMA DOUBLES DOWN ON SUMMER PRICE HIKES AS AMERICANS CONTINUE TO BATTLE PANDEMIC

Tracking Data Finds Drug Companies Increased Prices On at Least 67 Brand Name Drugs This Summer Despite Economic Crisis and Rising Concern With Rx Affordability For Immediate Release Contact: Jon

08-27-2020 Read More

CSRXP: BIG PHARMA’S COUNTEROFFER TO WHITE HOUSE WOULD HURT AMERICAN SENIORS & DO NOTHING TO LOWER DRUG PRICES

White House Should Reject Pharma-Backed Policies That Would Hand Drug Companies a Windfall on the Backs of American Taxpayers For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected]

08-26-2020 Read More

DOSE OF REALITY: TRUMP ADMINISTRATION MUST DUMP REBATE RULE TO ACHIEVE SECOND TERM GOAL OF LOWERING PREMIUMS

Misguided Measure Would Increase Medicare Part D Premiums, Cost Taxpayers More Than $200 Billion and Do Nothing To Lower Prescription Drug Prices On Monday, the Trump Administration released a list

08-26-2020 Read More

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.